Hikma Pharm Co Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HIKMA PHARM CO LTD, and what generic and branded alternatives to HIKMA PHARM CO LTD drugs are available?
HIKMA PHARM CO LTD has one approved drug.
Drugs and US Patents for Hikma Pharm Co Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma Pharm Co Ltd | ARGATROBAN | argatroban | INJECTABLE;INJECTION | 203049-001 | Jan 5, 2012 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hikma Pharm Co Ltd | ARGATROBAN | argatroban | INJECTABLE;INJECTION | 203049-002 | Sep 30, 2016 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for HIKMA PHARM CO LTD drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
Similar Applicant Names
Here is a list of applicants with similar names.